The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients is a research paper published in Science (2018). On theSindex it has a DataRank of 1.2. It has been cited 2,947 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.2
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: T32 CA009594
Melanoma Research Alliance
Grant: CA210098
NCI NIH HHS
Grant: F99 CA234946
NCI NIH HHS
Grant: R35 CA210098
University of Chicago Medicine Comprehensive Cancer Center
FWCI
100.32
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study
Additional file 1 of A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study
Additional file 1 of Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications
Additional file 1 of Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications
Additional file 2 of Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications
Additional file 2 of Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications
Additional file 1 of Bacterial community structure alterations within the colorectal cancer gut microbiome
Additional file 1 of Bacterial community structure alterations within the colorectal cancer gut microbiome
Additional file 1 of geneshot: gene-level metagenomics identifies genome islands associated with immunotherapy response
Additional file 1 of geneshot: gene-level metagenomics identifies genome islands associated with immunotherapy response
Additional file 4 of geneshot: gene-level metagenomics identifies genome islands associated with immunotherapy response
Additional file 4 of geneshot: gene-level metagenomics identifies genome islands associated with immunotherapy response
Additional file 5 of Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer
Additional file 5 of Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer
Additional file 2 of Genomic diversity and ecology of human-associated Akkermansia species in the gut microbiome revealed by extensive metagenomic assembly
Additional file 2 of Genomic diversity and ecology of human-associated Akkermansia species in the gut microbiome revealed by extensive metagenomic assembly
Additional file 3 of Genomic diversity and ecology of human-associated Akkermansia species in the gut microbiome revealed by extensive metagenomic assembly
Additional file 3 of Genomic diversity and ecology of human-associated Akkermansia species in the gut microbiome revealed by extensive metagenomic assembly
Additional file 2 of Relationship of the lung microbiome with PD-L1 expression and immunotherapy response in lung cancer
Additional file 2 of Relationship of the lung microbiome with PD-L1 expression and immunotherapy response in lung cancer